These findings suggest that adropin may be more used as a biomarker for predicting the risk of obesity and inflammation in Korean patients with T2DM, especially women.
Keyphrases
- insulin resistance
- metabolic syndrome
- weight loss
- high fat diet induced
- type diabetes
- weight gain
- end stage renal disease
- ejection fraction
- polycystic ovary syndrome
- newly diagnosed
- chronic kidney disease
- oxidative stress
- papillary thyroid
- adipose tissue
- prognostic factors
- skeletal muscle
- physical activity
- young adults
- risk assessment
- squamous cell carcinoma
- pregnant women
- climate change
- patient reported